Bristol Myers Squibb’s (BMS’s) investigational cereblon E3 ligase modulator iberdomide has shown promise in a mid-stage endpoint of a multiple myeloma trial. The ongoing Phase III EXCALIBER-RRMM study ...
Bristol Myers Squibb (BMS) has yet to announce official presentation plans at the 44 th annual JP Morgan Healthcare Conference, although Karin Shanahan, EVP, chief supply chain and operations officer, ...
Potential causes of a burning tongue include burns and scalds, certain medications, oral infections, and acid reflux. When this symptom is persistent, it is known as burning mouth syndrome (BMS). BMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback